In many life sciences organizations, clinical transparency is still handled as a last-minute process. Documents are exported, emailed, redacted in isolation, and stitched back together under deadline pressure.
It works, but only just. As disclosure volumes increase and regulatory expectations continue to rise, this reactive approach becomes harder to sustain.
Teams often deal with inconsistent decisions, unclear document histories, and manual workflows that introduce risk at every step. What once felt manageable quickly becomes difficult to scale across studies, regions, and regulatory requirements.
This is why many organizations are rethinking how transparency is managed. Rather than treating it as a final step, they are moving toward a more integrated approach that connects authoring, confidential information (CI) decisions, anonymization, and disclosure into a single, continuous process.
As regulatory expectations continue to expand across regions and disclosure volumes increase, this approach is no longer just inefficient. It becomes a risk to timelines, consistency, and compliance.
The Problem with Fragmented Transparency Workflows
When transparency is treated as a downstream activity, a predictable set of challenges emerges.
By the time disclosure begins, teams are often working with fragmented document sets. Multiple versions exist across systems, and there is limited visibility into what has already been reviewed or designated as confidential.
At the same time, CI and anonymization decisions are made late in the process, often under pressure and without full context. This leads to inconsistencies across submissions and increases the risk of both over-redaction and under-redaction.
The workflow itself is also disconnected. Documents are exported from one system, reviewed in another, tracked in spreadsheets, and shared through email. Each step introduces opportunities for error, version confusion, and potential data exposure.
In practice, this often leads to repeated redaction cycles, conflicting decisions across similar documents, and last-minute delays that impact submission timelines.
These are not just operational inefficiencies. They directly affect compliance, defensibility, and the ability to scale transparency across a growing portfolio.
A Shift Toward a Connected, Lifecycle Approach
To address these challenges, organizations are adopting a different mindset. Transparency is no longer treated as a standalone task at the end of the process. Instead, it is embedded across the entire clinical document lifecycle.
In this model, decisions about confidential information and anonymization begin earlier, during document authoring and review. These decisions are captured in a structured way and carried forward, rather than recreated under pressure at the point of disclosure.
This creates a more consistent and predictable process, where teams are not starting from zero with every submission.
This is often described as a connected or “one workflow” model. It links all stages of the transparency and disclosure lifecycle into a single, governed process where documents, decisions, and metadata move together.
What a Connected Workflow Looks Like in Practice
A connected workflow does not rely on a single platform doing everything. Instead, it brings together complementary capabilities into a unified process.
In practice, this enables organizations to apply consistent rules for identifying and managing confidential information across studies and regions. Governance is built into the workflow through structured reviews and auditable decision-making, rather than relying on informal processes or local tracking.
As volumes grow and regulatory requirements evolve, the same framework can scale without introducing additional complexity. Teams gain more predictable timelines and outcomes, reducing the need for last-minute effort.
Most importantly, documents no longer need to be manually moved between systems or reworked at each stage. Content, context, and decisions remain connected within a controlled environment, eliminating much of the friction seen in traditional approaches.
Enabling a Connected Workflow: Veeva as Architect and RLS as Structural Engineer
Delivering this kind of connected workflow requires more than a single tool. It depends on tightly integrated platforms that each play a distinct role.
In this model, Veeva acts as the architect of the content and disclosure environment, while Medispend’s Real Life Sciences Protect Platform (RLS) serves as the structural engineer for confidential information and anonymization.
Together, they create a unified system where each platform performs its role within a single, continuous workflow, without the need for manual handoffs or disconnected processes.
Veeva as the Architect
As the architect, Veeva defines the structure in which clinical and regulatory content is created, managed, and tracked.
It provides a system of record for studies, submissions, and documents, ensuring that each piece of content sits within the correct context. Structured authoring, review, and approval workflows support governance and accountability throughout the lifecycle.
Version control and lifecycle management ensure that teams always know which document is authoritative at any given time. At the same time, Veeva provides visibility across the disclosure process, allowing teams to track progress, identify bottlenecks, and align with regulatory timelines.
In effect, Veeva establishes the blueprint that organizes and governs the entire content environment.
RLS Protect Platform as the Structural Engineer
Real Life Sciences complements this by focusing on how sensitive information is identified, managed, and protected.
As the structural engineer, it ensures that confidential information and patient data are handled consistently and defensibly across the workflow.
This includes identifying and managing CI through centralized libraries, applying consistent rules across documents and programs, and systematically anonymizing patient-level data based on defined risk thresholds.
Governance is built into the process through structured review workflows and detailed audit trails, capturing what decisions were made, when they were made, and why.
AI and NLP capabilities further support this by surfacing potential confidential information for review, helping teams improve coverage without removing human oversight.
If Veeva defines the structure, Real Life Sciences ensures that the structure is sound and capable of withstanding regulatory and commercial scrutiny.
How the Integration Works in Practice
The value of this model comes from how these roles are connected through integration.
Within Veeva, users initiate requests for CI review, anonymization, and redaction directly in the context of specific documents and submissions. This ensures that downstream processes begin with the right level of context.
Documents then flow into Real Life Sciences, where CI policies, anonymization rules, and governance workflows are applied. Decisions are captured, managed, and fully audited within a controlled environment.
Once processing is complete, documents return to Veeva automatically in the correct lifecycle state, with appropriate versioning and all relevant CI decisions attached.
From a user perspective, this operates as a single workflow. There is no need for manual exports, email-based coordination, or spreadsheet tracking. Sensitive content remains within a governed ecosystem from start to finish.
From Reactive Processes to Scalable Transparency
This architect and structural engineer model fundamentally changes how organizations approach transparency.
Instead of managing disclosure as a series of disconnected tasks, teams operate within a designed system where decisions are made earlier, applied consistently, and fully traceable.
Manual risks are reduced, processes become more predictable, and transparency efforts can scale across portfolios and regions without a corresponding increase in complexity.
As regulatory expectations continue to evolve, this shift becomes essential. Those that continue to rely on fragmented, manual approaches will find it increasingly difficult to keep pace with these demands.
Organizations that adopt a connected workflow are better positioned to deliver transparency that is consistent, defensible, and scalable, without the operational strain of reactive redaction.
Ultimately, this is the transition from managing transparency as an activity to designing it as a system.
Nirpal Virdee
Vice President, Regulatory Science
